New positive preclinical data on the anti-tumor potency of LP-184 for TNBCs was recently presented at the San Antonio Breast Cancer Symposium (SABCS) ...
News
- Lantern Pharma Announces Development of Drug Candidate LP-184 for Triple Negative ...
- vTv Therapeutics (VTVT) Appoints Biotech Industry Veteran Steven Tuch as Chief Financial Officer
... Lantern Pharma (LTRN) Announces Development of Drug Candidate LP-184 for Triple Negative Breast Cancer (TNBC) at the San Antonio Breast Cancer ...
- Blue Water Vaccines Announces Institutional Research Coverage by Two Notable ... - BioSpace
... Cincinnati Children's Hospital Medical Center, St. Jude Children's Hospital, and The University of Texas Health San Antonio.
- Texas Elite Fence & Deck, an Experienced Deck Builder, Offers Free Estimates & Quotes
San Antonio, TX: Texas Elite Fence & Deck offers free quotes on all deck-building projects. Whether a homeowner wants to add aesthetic appeal to ...
- National Academy of Inventors to induct Jean Jiang, PhD, of UT Health
Proteins called connexins also form smaller channels that the researchers call “hemichannels.” UT Health San Antonio in 2017 entered multimillion- ...